Research Projects
-
Bin Ye, PhD,
Brigham and Women’s Hospital, Dana Farber Cancer Institute
Individual Investigator AwardFinding Serum and Urine Protein/Peptide Markers of Ovarian Cancer for Screening
-
Elizabeth Ann Poynor, MD,
Memorial Sloan Kettering Cancer Center
Individual Investigator AwardThe Role of a Novel Gene, ZIC 2, in Causing Sporadic Ovarian Cancer
-
Rebecca Liu, MD,
University of Michigan
Early Career Investigator GrantDysfunctional Apoptosome Activation in Ovarian Cancer: Implications for Pathogenesis, Prognosis, and Chemoresistance
-
Kimberly Kalli, PhD,
Mayo Clinic
Early Career Investigator GrantFunctional Significance of Insulin Receptors in Epithelial Ovarian Cancer: Therapeutic Implications
-
Steven W. Johnson, PhD,
University of Pennsylvania
Individual Investigator AwardCharacterizing Differential Gene Expression of Drug Sensitive and Resistant Ovarian Cancer
-
Paul Cairns, PhD,
Fox Chase Cancer Center
Individual Investigator AwardNovel Approaches for Early Diagnosis of Ovarian Cancer
-
Christina Bandera, MD,
Dana Farber Cancer Institute
Early Career Investigator GrantThe Molecular Basis of Recurrent Ovarian Cancer and Primary Peritoneal Cancer
-
Karen H. Lu, MD,
MD Anderson Cancer Center
Early Career Investigator GrantUnderstanding the Molecular Differences in Histologic Grades of Ovarian Cancer: Implications for Discovering New Prognostic Markers
-
Gary Yiu, PhD,
Brigham and Women’s Hospital, Dana Farber Cancer Institute
Individual Investigator AwardMolecular Classification of Epithelial Ovarian Tumors
-
Xiang-Xi Xu, PhD,
Fox Chase Cancer Center
Individual Investigator AwardStudying the Role of a Novel Protein, Dab2, in Ovarian Cancer
-
Christos Patriotis, PhD,
Fox Chase Cancer Center
Early Career Investigator GrantMolecular Genetic Mechanisms of Ovarian Oncogenesis
-
Iman Osman, MD,
University of New Mexico
Individual Investigator AwardHypoxia Inducible Factor-1 alpha (HIF-1): A Potential New Prognostic Marker for Advanced Ovarian Cancer and Target of Treatment